Gregor Novak

Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission

Jurij Hanžel, Jurij Zdovc, Tina Kurent et al. · Clinical Gastroenterology and Hepatology · 2020 · 51 citations · Full text

Immunology, Gastroenterology, Biochemical Remission +5

Success and safety of high infliximab trough levels in inflammatory bowel disease

David Drobne, Tina Kurent, Saša Golob et al. · Scandinavian Journal of Gastroenterology · 2018 · 46 citations

Natural History and Risk Stratification of Recurrent Crohn’s Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study

V Joustra, Marjolijn Duijvestein, Aart Mookhoek et al. · Inflammatory Bowel Diseases · 2021 · 42 citations · Full text

Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease

David Drobne, Tina Kurent, Saša Golob et al. · Alimentary Pharmacology & Therapeutics · 2019 · 40 citations

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease

Gregor Novak, Toer Stevens, Tanja van Viegen et al. · Alimentary Pharmacology & Therapeutics · 2019 · 29 citations · Full text